-
-
-
-
-
-
-
Amneal Pharmaceuticals (AMRX) Tops Q2 EPS by 7c ; Offers Guidance
-
-
-
-
-
-
-
Amneal reports positive interim results for Parkinson's drug CREXONT
-
-
-
-
-
-
-
Amneal agrees to acquire Kashiv BioSciences for $750 million
-
-
-
-
-
-
-
Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson’s Awareness Month
-
-
-
-
-
-
-
AMNEAL receives FDA approval for epinephrine injection vials
-
-
-
-
-
-
-
Amneal Announces U.S. FDA Approval of Cyclosporine Ophthalmic Emulsion 0.05%
-
-
-
-
-
-
-
Amneal Launches Brekiya® – the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches
-
1,231,050 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


